In vitro studies have shown that CA-170 presents antagonistic effects on the PD-1/PD-L1/VISTA signaling pathway, promoting tumor infiltration and peripheral T-cell viability in a dose-dependent manner. The gene discussed is VSIR; the disease is neoplasm.